Thermo Fisher Scientific SPG11 Recombinant Rabbit Monoclonal Antibody (2H25L11)

Applications

Product Specifications

Product Specific Information

This antibody is predicted to react with Monkey, Horse, Bovine, and Sheep.

Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems developed by cloning specific antibody DNA sequences from immunoreactive rabbits. Individual clones are screened to select optimal production candidates.

Advantages of recombinant rabbit monoclonal antibodies:

• Excellent specificity and sensitivity
• Lot-to-lot consistency
• Animal origin-free formulations
• Broader immunoreactivity due to larger rabbit immune repertoire

Target Information

Hereditary spastic paraplegias (HSPs) are genetically and phenotypically heterogeneous disorders. Spastic paraplegia with thinning of the corpus callosum (ARHSP-TCC) is a frequent form of complicated hereditary spastic paraplegia (cHSP) characterized by mental retardation and muscle stiffness followed by progressive paraparesis and cognitive deterioration.

Mutations in the SPG11 gene, encoding spatacsin, are a major cause of HSP-TCC. Spatacsin is a potential transmembrane protein phosphorylated upon DNA damage and expressed throughout the brain, with high levels in the cerebellum. SPG11 mutations may be more common in familial cHSP forms. Kjellin syndrome and juvenile Parkinsonism have also been linked to SPG11 mutations.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

제품 이미지